Press Releases CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Market Closed - OTC Markets Other stock markets 10:49:38 14/05/2024 pm IST			5-day change	1st Jan Change
0.0107 ^USD	+12.22%		+2.88%	-24.65%

16/04	CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
12/01	CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05/23/05	AQ
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02/23/02	AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/23/14	AQ
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08/23/08	AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/23/13	AQ
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	30/22/30	AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/22/30	AQ
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08/22/08	PR
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18/22/18	PR
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel	13/22/13	PR
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate	29/22/29	PR
CNBX Pharmaceuticals Announces New Patent Granted in Australia	28/22/28	PR
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	25/22/25	AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/22/14	AQ
CNBX Pharmaceuticals Release a New Corporate Presentation	31/22/31	PR
CNBX Pharmaceuticals Granted Patent in Hong Kong	05/22/05	PR
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/22/12	AQ
Cannabics Pharmaceuticals : Changes Name to CNBX Pharmaceuticals - Form 8-K	29/22/29	PU
CNBX PHARMACEUTICALS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	29/22/29	AQ
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals	28/22/28	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Press Releases

Filters